Komori
Other Disclosures4918IVY COSMETICS CORPORATIONMaterials and Chemicals

Notice of Research Presentations at the 72nd Annual Meeting of the Japanese Society of Pharmacognosy

At the annual meeting of the Japanese Society of Pharmacognosy, the company identified a plant extract that suppresses immune signals involved in skin inflammation and presented its research findings. At this time, there is no impact on current-period results.

Worth reading
57In focus
Scored from 4 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

New plant extract (specific name: Not disclosed)
Applicable field (uses covered by this announcement)

Skin immunity, skin inflammation, chronic skin diseases, creation of pharmacognosy resources

What the company reported numerically
Quantitative Effects

Identified a plant extract that suppresses key signal transduction pathways involved in immune responses, including the NF-κB pathway

Relationship between the counterparty and the company
IVY COSMETICS CORPORATION4918
Relationship with the Company

Relevant academic society serving as a venue for research presentations

CounterpartyJapanese Society of Pharmacognosy

An academic society related to pharmacognosy. Other details: Not disclosed.

Impact on Business Performance

At this time, there is no impact on results for the current fiscal year

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

72nd Annual Meeting of the Japanese Society of Pharmacognosy

Announced details
ItemDetails
Names of Products / Services CoveredNew plant extract (specific name: Not disclosed)
CounterpartyJapanese Society of Pharmacognosy
Counterparty overviewAn academic society related to pharmacognosy. Other details: Not disclosed.
Relationship with the CompanyRelevant academic society serving as a venue for research presentations
Applicable areaSkin immunity, skin inflammation, chronic skin diseases, creation of pharmacognosy resources
Quantitative EffectsIdentified a plant extract that suppresses key signal transduction pathways involved in immune responses, including the NF-κB pathway
Impact on Business PerformanceAt this time, there is no impact on results for the current fiscal year
Source72nd Annual Meeting of the Japanese Society of Pharmacognosy
Items this document does not state (10)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage history

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Plant extracts were screened using their ability to suppress immune response signals as an indicator, with the aim of creating new pharmacognosy resources for treating skin inflammatory conditions.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Research Presentations at the 72nd Annual Meeting of the Japanese Society of Pharmacognosy | IVY COSMETICS CORPORATION (4918) timely disclosure | Komori